Hilde Engerud
Bergen, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Expression patterns of mismatch repair proteins in cervical cancer uncover independent prognostic value of MSH-2.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: July 01, 2024
Mismatch repair markers in preoperative and operative endometrial cancer samples; expression concordance and prognostic value.
Journal: British journal of cancer
Published: January 24, 2022
A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease.
Journal: British journal of cancer
Published: December 22, 2020
Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study.
Journal: PLoS medicine
Published: December 03, 2019
High degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer.
Journal: Gynecologic oncology
Published: October 15, 2019
Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study.
Journal: American journal of obstetrics and gynecology
Published: March 14, 2017
High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors.
Journal: British journal of cancer
Published: February 13, 2014
Molecular profiling in fresh tissue with high tumor cell content promotes enrichment for aggressive adenocarcinomas in cervix.
Journal: Pathology, research and practice
Published: January 31, 2014
Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas.
Journal: Gynecologic oncology
Published: June 24, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026